Taking the occasional loss comes part and parcel with investing on the stock market. Anyone who held The Beauty Health Company (NASDAQ:SKIN) over the last year knows what a loser feels like. In that relatively short period, the share price has plunged 63%. We wouldn’t rush to judgement on Beauty Health because we don’t have a long term history to look at. Furthermore, it’s down 24% in about a quarter. That’s not much fun for holders. This could be related to the recent financial results – you can catch up on the most recent data by reading our company report.
If the past week is anything to go by, investor sentiment for Beauty Health isn’t positive, so let’s see if there’s a mismatch between fundamentals and the share price.
View our latest analysis for Beauty Health
Given that Beauty Health didn’t make a profit in the last twelve months, we’ll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
Beauty Health grew its revenue by 74% over the last year. That’s a strong result which is better than most other loss making companies. In contrast the share price is down 63% over twelve months. Yes, the market can be a fickle mistress. Typically a growth stock like this will be volatile, with some shareholders concerned about the red ink on the bottom line (that is, the losses). Generally speaking investors would consider a stock like this less risky once it turns a profit. But when do you think that will happen?
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
Beauty Health is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.
A Different Perspective
Beauty Health shareholders are down 63% for the year, even worse than the market loss of 24%. There’s no doubt that’s a disappointment, but the stock may well have fared better in a stronger market. With the stock down 24% over the last three months, the market doesn’t seem to believe that the company has solved all its problems. Given the relatively short history of this stock, we’d remain pretty wary until we see some strong business performance. You might want to assess this data -rich visualization of its earnings, revenue and cash flow.
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.
Valuation is complex, but we’re helping make it simple.
Find out whether Beauty Health is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.